Cargando…

AGE-BASED RISK FACTORS FOR SYMPTOMATIC COVID-19 IN THE MINORITY POPULATION

Detalles Bibliográficos
Autores principales:	Gurbel, Paul A., Chaudhary, Rahul, Bliden, Kevin, Cho, Alastair, Tantry, Udaya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2021
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091414/ http://dx.doi.org/10.1016/S0735-1097(21)04534-4

Ejemplares similares

IS THERE A ROLE FOR α1-ANTITRYPSIN IN COVID-19?
por: Gurbel, Paul A., et al.
Publicado: (2021)

IS LOW DOSE ASPIRIN EFFECTIVE IN REDUCING IN-HOSPITAL CLINICAL OUTCOMES IN PATIENTS WITH COVID-19?
por: Gurbel, Paul A., et al.
Publicado: (2021)

DO ELECTIVE CARDIAC PROCEDURES INCREASE THE RISK OF SYMPTOMATIC COVID-19 TRANSMISSION WITH CURRENT HOSPITAL PRECAUTIONARY MEASURES?
por: Suhotliv, Amy, et al.
Publicado: (2021)

Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population
por: Gurbel, Paul A., et al.
Publicado: (2021)

Further evidence for the use of aspirin in COVID-19
por: Tantry, Udaya S., et al.
Publicado: (2022)

RISK OF CARDIOVASCULAR COMPLICATIONS IN ETHNIC MINORITIES INFECTED WITH COVID-19 - EXPERIENCE IN A MID-SIZED MIDWESTERN CITY
por: Desai, Viral, et al.
Publicado: (2021)

INCIDENCE OF ARRHYTHMIAS AND ELECTROCARDIOGRAPHIC CHANGES IN ETHNIC MINORITY PATIENTS WITH COVID- 19 INFECTION
por: Jadhav, Preeti, et al.
Publicado: (2021)

IMPACT OF TELEMEDICINE NETWORK PROVIDED BY LOCAL PHARMACIES IN THE MANAGEMENT OF SYMPTOMATIC TACHYARRHYTMIAS DURING COVID-19 OUTBREAK
por: Nodari, Savina, et al.
Publicado: (2021)

ELEVATION OF NT-PROBNP LEVEL IS ASSOCIATED WITH HIGHER IN-HOSPITAL MORTALITY FOR COVID-19 IN ETHNIC MINORITY COMMUNITY
por: Jadhav, Preeti, et al.
Publicado: (2021)

IS HYPERTENSION (HTN) AN INDEPENDENT RISK FACTOR FOR MORTALITY IN COVID-19 PATIENTS?
por: Mughal, Mohsin, et al.
Publicado: (2021)

Race-Related disparities in COVID-19 thrombotic outcomes: Beyond social and economic explanations
por: Chaudhary, Rahul, et al.
Publicado: (2020)

FORMER INCARCERATION AS A RISK FACTOR FOR COVID-19 ASSOCIATED SUDDEN DEATH
por: Raghunathan, Sahana, et al.
Publicado: (2022)

RISK FACTORS OF ARTERIAL THROMBOEMBOLISM IN HOSPITALIZED COVID-19 PATIENTS: A MULTICENTER COHORT STUDY
por: Lee, Yi, et al.
Publicado: (2022)

RISK FACTORS ASSOCIATED WITH ICU ADMISSION AND DEATH AMONG COVID-19 PATIENTS IN A LARGE ACADEMIC HEALTHCARE NETWORK
por: Meena, Richard, et al.
Publicado: (2021)

RISK FACTORS FOR COVID-19 RELATED MORTALITY- A SYSTEMATIC REVIEW AND META-ANALYSIS OF 26 STUDIES AND 9690 PATIENTS
por: Goel, Sunny, et al.
Publicado: (2021)

UTILITY OF AN AUTOMATED ARTIFICIAL INTELLIGENCE ECHOCARDIOGRAPHY SOFTWARE IN RISK STRATIFICATION OF HOSPITALIZED COVID-19 PATIENTS
por: Wang, Tom Kai Ming, et al.
Publicado: (2021)

Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes
por: Usman, Abira, et al.
Publicado: (2022)

WHO IS AT RISK FOR CARDIOMYOPATHY IN COVID 19
por: Daftari, Diana, et al.
Publicado: (2021)

META-ANALYSIS OF SAFETY AND EFFICACY OF RENIN ANGIOTENSIN ALDOSTERONE SYSTEM INHIBITORS IN COVID-19 POPULATION
por: Sattar, Yasar, et al.
Publicado: (2021)

AGE AS A PREDICTOR OF MORTALITY IN PATIENTS ADMITTED WITH COVID-19, A RETROSPECTIVE STUDY OF 6,000 PATIENTS
por: Abualfoul, Mujahed, et al.
Publicado: (2022)

RISK PREDICTORS FOR MYOCARDIAL INJURY IN SEVERE COVID-19
por: Nascimento, Jorge H.P., et al.
Publicado: (2021)

IMPACT OF THROMBOPROPHYLACTIC STRATEGY ON BLEEDING RISK AMONG IN- AND OUTPATIENTS WITH COVID-19
por: Svet, Mark, et al.
Publicado: (2021)

DOES ABO BLOOD GROUP INFLUENCE RISK OR SEVERITY OF COVID-19?
por: Anderson, Jeffrey L., et al.
Publicado: (2021)

COVID-19 VACCINES AND ATRIAL FIBRILLATION RISK: A PHARMACOVIGILANCE ANALYSIS
por: Kattubadi, Ayeesha, et al.
Publicado: (2022)

AGE-RELATED EFFECTS OF COVID-19 PANDEMIC ON MECHANICAL REPERFUSION AND 30-DAY MORTALITY FOR STEMI: RESULTS OF THE ISACS-STEMI COVID-19 REGISTRY
por: Verdoia, Monica, et al.
Publicado: (2022)

RELATION OF 10-YEAR ASCVD RISK SCORE WITH SEVERE COVID-19 OUTCOMES
por: Arif, Yousif, et al.
Publicado: (2022)

PREDICTING COVID-19 INPATIENT MORTALITY AND MORBIDITY BY USING CARDIOVASCULAR RISK SCORES
por: Ahmed, Eyad, et al.
Publicado: (2021)

PERFORMANCE OF CURRENT THROMBOEMBOLISM RISK ASSESSMENT TOOLS IN PATIENTS WITH SEVERE COVID-19
por: Rios, Luis H. Paz, et al.
Publicado: (2021)

SOLUBLE P-SELECTIN, PLATELET ACTIVITY AND RISK OF MORBIDITY AND MORTALITY IN COVID-19
por: Mosarla, Ramya, et al.
Publicado: (2022)

OUTCOMES AND READMISSION RISK OF CRITICALLY ILL COVID-19 PATIENTS WITH CARDIOVASCULAR OUTCOMES
por: Manjappachar, Nirmala, et al.
Publicado: (2022)

VASCULAR ENDOTHELIAL GROWTH FACTOR IS ASSOCIATED WITH SEVERE COVID-19 DISEASE
por: Solorzano, Juan, et al.
Publicado: (2022)

HIGH-SENSITIVITY CARDIAC TROPONIN T FOR THE DETECTION OF MYOCARDIAL INJURY AND RISK STRATIFICATION IN COVID-19
por: De Michieli, Laura, et al.
Publicado: (2021)

RISK OF RECURRENT MYOCARDITIS FOLLOWING COVID-19 MRNA VACCINATION IN ADULTS WITH PRIOR HISTORY
por: Simone, Anthony, et al.
Publicado: (2022)

TROPONIN-I PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AND RISK OF MORTALITY IN COVID-19 PATIENTS
por: Patel, Chirag, et al.
Publicado: (2021)

THE ROLE OF ABO BLOOD GROUP TYPING IN RISK STRATIFYING PATIENTS WITH THE NOVEL CORONAVIRUS 2019-NCOV
por: Shadid, Husam, et al.
Publicado: (2021)

SERUM BIOMARKERS IN MORTALITY RISK STRATIFICATION IN PATIENTS, HOSPITALIZED WITH COVID-19 PNEUMONIA IN EARLY AND REMOTE PERIOD
por: Zagidullin, Naufal, et al.
Publicado: (2022)

COVID-19 RISK PERCEPTION AND IDENTIFICATION OF APPROPRIATE MITIGATION STRATEGIES AMONG ADULTS WITH CONGENITAL HEART DEFECTS
por: Jackson, Jamie, et al.
Publicado: (2022)

ECHOCARDIOGRAPHIC ABNORMALITIES ARE COMMON AMONG PATIENTS WITH COVID-19 INFECTION AND INDEPENDENTLY CONFER INCREASED RISK OF IN-HOSPITAL MORTALITY
por: Homan, Edwin A., et al.
Publicado: (2021)

RETURN TO PLAY EVALUATION POST COVID - LONGITUDINAL EXPERIENCE IN CARDIAC RISK ASSESSMENT AT A DIVISION I ATHLETIC PROGRAM
por: Sivalokanathan, Sanjay, et al.
Publicado: (2023)

PSYCHOSOCIAL FACTORS AMONG A SAMPLE OF CARDIAC REHABILITATION PATIENTS THAT HAVE GONE THROUGH COVID19 INFECTION
por: Coello, Mercedes, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0c93ao1qqpqgo8ggq5mar5ig19